2022
DOI: 10.1101/2022.03.04.22271825
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Efficacy of LD BioAspergillus ICT Lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis

Abstract: Background: The diagnosis of CPA relies on the detection of IgG Aspergillus antibody which is not freely available, especially in resource-poor settings. Point-of-care tests like LDBio Aspergillus ICT lateral flow assay, evaluated in only a few studies, have shown promising results for diagnosis of CPA. However no study has compared the diagnostic performances of LDBio LFA in setting of tuberculosis endemic countries and have compared it with that of IgG Aspergillus. Objectives: This study aimed to evaluate… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
references
References 34 publications
(44 reference statements)
0
0
0
Order By: Relevance